Papers: 10.1186/s12931-020-01398-w

https://doi.org/10.1186/s12931-020-01398-w

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

Cited by: 10
Author(s): Nicola C. Day, Subramanya Kumar, Gerard J. Criner, Mark T. Dransfield, David Halpin, MeiLan K. Han, Christine Jones, Morrys C. Kaisermann, Sally Kilbride, Peter Lange, David A. Lomas, Neil Martin, Fernando J. Martínez, Dave Singh, Robert A. Wise, David A. Lipson
Published: about 5 years ago

Software Mentions 1